|
DE1470356A1
(de)
|
1964-01-15 |
1970-04-30 |
Thomae Gmbh Dr K |
Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
|
|
JP3126541B2
(ja)
|
1993-03-26 |
2001-01-22 |
千寿製薬株式会社 |
ベンゾチアゾール誘導体、その製法及びその用途
|
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
NZ335823A
(en)
|
1997-04-22 |
2001-06-29 |
Neurocrine Biosciences Inc |
Thiophenopyridines, preparation as CRF receptor antagonists
|
|
SK6652000A3
(en)
|
1997-11-11 |
2002-05-09 |
Pfizer Prod Inc |
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
|
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
|
WO2005007083A2
(en)
|
2003-06-18 |
2005-01-27 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2005033290A2
(en)
|
2003-10-03 |
2005-04-14 |
The General Hospital Corporation |
Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
|
|
JP2009007341A
(ja)
|
2007-06-01 |
2009-01-15 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
|
EP2014663A1
(de)
|
2007-07-12 |
2009-01-14 |
Bayer Schering Pharma AG |
Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
|
|
WO2009085226A2
(en)
|
2007-12-21 |
2009-07-09 |
Sirtris Pharmaceuticals, Inc. |
Inhibitors of cdc2-like kinases (clks) and methods of use thereof
|
|
KR101616140B1
(ko)
|
2008-03-05 |
2016-04-27 |
다케다 야쿠힌 고교 가부시키가이샤 |
복소환 화합물
|
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
|
US20130209549A1
(en)
|
2010-07-21 |
2013-08-15 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
US20130317045A1
(en)
|
2010-09-01 |
2013-11-28 |
Ambit Biosciences Corporation |
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
|
DE102011111400A1
(de)
|
2011-08-23 |
2013-02-28 |
Merck Patent Gmbh |
Bicyclische heteroaromatische Verbindungen
|
|
EA025186B1
(ru)
|
2012-06-29 |
2016-11-30 |
Пфайзер Инк. |
НОВЫЕ 4-(ЗАМЕЩЕННЫЙ АМИНО)-7Н-ПИРРОЛО[2,3-d]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LRRK2
|
|
AU2014214561C1
(en)
|
2013-02-11 |
2019-01-17 |
Mitokinin, Inc. |
Compositions and methods for treating neurodegenerative diseases
|
|
EP2964654A4
(en)
|
2013-03-07 |
2016-08-10 |
Glaxosmithkline Llc |
THIEN [3,2-D] PYRIMIDIN-6-CARBOXAMIDE AND ANALOGUE AS SIRTUIN MODULATORS
|
|
US9217148B2
(en)
|
2013-03-14 |
2015-12-22 |
Sarepta Therapeutics, Inc. |
Exon skipping compositions for treating muscular dystrophy
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
US9879014B2
(en)
*
|
2013-07-12 |
2018-01-30 |
Kyoto University |
Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease
|
|
WO2015053624A2
(en)
|
2013-10-07 |
2015-04-16 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansions
|
|
KR102390370B1
(ko)
|
2014-02-12 |
2022-04-26 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
SG11201609016VA
(en)
|
2014-04-30 |
2016-11-29 |
Incyte Corp |
Processes of preparing a jak1 inhibitor and new forms thereto
|
|
CA3199430A1
(en)
|
2015-01-16 |
2016-07-21 |
The General Hospital Corporation |
Compounds for improving mrna splicing
|
|
BR122023023802A2
(pt)
|
2015-04-29 |
2023-12-26 |
Janssen Pharmaceutica Nv |
Compostos azabenzimidazóis, seu uso como moduladores do receptor de ampa e composições farmacêuticas que os compreendem
|
|
CN108137641B
(zh)
|
2015-08-13 |
2022-04-01 |
默沙东公司 |
作为sting激动剂的环状双核苷酸化合物
|
|
WO2017053781A1
(en)
|
2015-09-25 |
2017-03-30 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating ataxin 3 expression
|
|
CA3119019C
(en)
|
2015-12-10 |
2024-06-11 |
Ptc Therapeutics, Inc. |
Compounds and methods for treating huntington's disease
|
|
US10034861B2
(en)
|
2016-07-04 |
2018-07-31 |
H. Lundbeck A/S |
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
|
|
EP3494229B1
(en)
|
2016-08-03 |
2023-10-25 |
Meiragtx UK II Limited |
High throughput cell-based screening for aptamers
|
|
CN110300590A
(zh)
|
2016-10-21 |
2019-10-01 |
林伯士拉克许米公司 |
Tyk2抑制剂及其用途
|
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
CN110312528B
(zh)
|
2017-02-20 |
2022-02-18 |
国立大学法人京都大学 |
用于起因于剪接异常的遗传性疾病的药物组合物及治疗方法
|
|
IL274702B2
(en)
|
2017-11-27 |
2026-04-01 |
Coda Biotherapeutics Inc |
Compounds and methods for neurological diseases
|
|
US12503467B2
(en)
|
2018-12-10 |
2025-12-23 |
Ideaya Biosciences, Inc. |
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
|
|
CN109819066A
(zh)
|
2019-01-31 |
2019-05-28 |
平安科技（深圳）有限公司 |
一种基于地理位置的智能解析域名方法及装置
|
|
AU2020222881C1
(en)
|
2019-02-13 |
2026-01-22 |
Ptc Therapeutics, Inc. |
Thioeno(3,2-b) pyridin-7-amine compounds for treating familial dysautonomia
|
|
CR20210426A
(es)
|
2019-02-13 |
2021-09-30 |
Denali Therapeutics Inc |
Compuestos, composiciones y métodos
|
|
WO2020167624A1
(en)
|
2019-02-13 |
2020-08-20 |
Ptc Therapeutics, Inc. |
Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia
|
|
EP3929185A4
(en)
|
2019-02-19 |
2023-02-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
NITROGEN CONDENSED CYCLIC COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
|
WO2020245233A1
(en)
|
2019-06-06 |
2020-12-10 |
F. Hoffmann-La Roche Ag |
Antisense oligonucleotides targeting atxn3
|
|
KR102537214B1
(ko)
|
2019-11-26 |
2023-05-31 |
주식회사 고영테크놀러지 |
자기 공명 이미지들에서 정중시상 평면을 결정하기 위한 방법 및 장치
|
|
KR20220113700A
(ko)
|
2019-12-12 |
2022-08-16 |
피티씨 테라퓨틱스, 인크. |
가족성 자율신경실조증 치료를 위한 화합물
|
|
US20230117831A1
(en)
|
2020-01-08 |
2023-04-20 |
The Broad Institute, Inc. |
Multi-functional chimeric molecules
|
|
US20240051968A1
(en)
|
2021-02-05 |
2024-02-15 |
Ptc Therapeutics, Inc. |
Methods for treating spinocerebellar ataxia type 3
|
|
EP4288059A4
(en)
|
2021-02-05 |
2025-01-08 |
PTC Therapeutics, Inc. |
Compounds for treating spinocerebellar ataxia type 3
|
|
WO2022169864A1
(en)
|
2021-02-05 |
2022-08-11 |
Ptc Therapeutics Inc. |
Methods for treating spinocerebellar ataxia type 3
|
|
US20240024490A1
(en)
|
2021-04-09 |
2024-01-25 |
The Broad Institute, Inc. |
Bifunctional molecules for selective modification of target substrates
|
|
JP2024533264A
(ja)
|
2021-09-07 |
2024-09-12 |
ピーティーシー セラピューティクス， インコーポレイテッド |
神経原性疾患を処置するための方法
|
|
MX2024002886A
(es)
|
2021-09-07 |
2024-05-24 |
Ptc Therapeutics Inc |
Metodos para tratar enfermedades neurodegenerativas.
|
|
CA3231007A1
(en)
|
2021-09-07 |
2023-03-16 |
Scott J. Barraza |
Methods for treating neurogenerative diseases
|
|
EP4426702A1
(en)
|
2021-11-04 |
2024-09-11 |
Skyhawk Therapeutics, Inc. |
Condensed-pyrazine amine derivatives for treating sca3
|
|
CN119997954A
(zh)
|
2022-06-22 |
2025-05-13 |
Ptc医疗公司 |
用于治疗脊髓小脑性共济失调3型的化合物
|